Health Centered Co., Ltd., a company specializing in the development of anti-aging health functional foods, announced that it has signed a business partnership agreement with Kyungbang Shinyak Co., Ltd. to strengthen research, development, and distribution cooperation on senolytic technology utilizing cryptotanshinone, a key ingredient of red ginseng.
Through this agreement, the two companies aim to commercialize innovative health functional foods for improving aging and prostate health by combining Kyungbang Shinyak’s oriental medicine science know-how with Health Centered’s cryptotanshinone-based senolytic technology, providing a health promotion solution through the removal of aging cells and improvement of energy metabolism.
Kyungbang Shinyak is an innovative company that has led the way in oriental medicine science and contributed to the modern research and development of natural medicines and their popularization. Through this collaboration, it is expected that the effectiveness and safety of natural product-based health functional foods using senolytic technology will be maximized.
Senolytic technology is expected to delay the aging of the body and improve prostate health and energy metabolism by selectively removing senescent cells by weakening the survival pathways of senescent cells (SCAPs, Senescent Cell Anti-Apoptotic Pathways). Cryptotanshinone is a key ingredient that helps this senolytic action, promoting NAD production to increase cell vitality and improve aging-related metabolic functions.
Park Young-ho, CEO of Health-Centered, said, “We will develop an innovative senolytic product based on cryptotanshinone by combining Kyungbang Shinyak’s natural herbal medicine technology,” and “We will introduce a next-generation health functional food that can fundamentally improve aging and prostate health.”
- See more related articles
You must be logged in to post a comment.